HEADER HYDROLASE/HYDROLASE INHIBITOR 21-NOV-12 4I1R TITLE HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH THIORIDAZINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION COMPND 3 PROTEIN 1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: MALT LYMPHOMA-ASSOCIATED TRANSLOCATION, PARACASPASE; COMPND 6 EC: 3.4.22.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MALT1, MLT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.SCHLAUDERER,K.LAMMENS,K.P.HOPFNER REVDAT 3 28-FEB-24 4I1R 1 REMARK SEQADV REVDAT 2 16-OCT-13 4I1R 1 JRNL REVDAT 1 28-AUG-13 4I1R 0 JRNL AUTH F.SCHLAUDERER,K.LAMMENS,D.NAGEL,M.VINCENDEAU,A.C.EITELHUBER, JRNL AUTH 2 S.H.VERHELST,D.KLING,A.CHRUSCIEL,J.RULAND,D.KRAPPMANN, JRNL AUTH 3 K.P.HOPFNER JRNL TITL STRUCTURAL ANALYSIS OF PHENOTHIAZINE DERIVATIVES AS JRNL TITL 2 ALLOSTERIC INHIBITORS OF THE MALT1 PARACASPASE. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 52 10384 2013 JRNL REFN ISSN 1433-7851 JRNL PMID 23946259 JRNL DOI 10.1002/ANIE.201304290 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.09 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 10386 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.820 REMARK 3 FREE R VALUE TEST SET COUNT : 1020 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2928 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2454 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2632 REMARK 3 BIN R VALUE (WORKING SET) : 0.2373 REMARK 3 BIN FREE R VALUE : 0.3179 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.11 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 296 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2803 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 26 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 86.51 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 105.1 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.40070 REMARK 3 B22 (A**2) : -11.77340 REMARK 3 B33 (A**2) : 5.37270 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 19.82370 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.510 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2884 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3894 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1034 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 76 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 401 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2884 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 365 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3226 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.23 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.65 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 23.19 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|338 - A|720 } REMARK 3 ORIGIN FOR THE GROUP (A): -21.3496 -17.6955 8.9455 REMARK 3 T TENSOR REMARK 3 T11: -0.1141 T22: 0.0145 REMARK 3 T33: -0.1330 T12: 0.0862 REMARK 3 T13: -0.0839 T23: -0.0610 REMARK 3 L TENSOR REMARK 3 L11: 3.2439 L22: 1.3351 REMARK 3 L33: 3.9010 L12: 1.4195 REMARK 3 L13: 2.7563 L23: 0.5081 REMARK 3 S TENSOR REMARK 3 S11: 0.0573 S12: 0.0417 S13: 0.1411 REMARK 3 S21: -0.0406 S22: -0.0541 S23: 0.1228 REMARK 3 S31: -0.1108 S32: 0.0268 S33: -0.0032 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4I1R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-NOV-12. REMARK 100 THE DEPOSITION ID IS D_1000076194. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.972390 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 1667 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 41.090 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 M MAGNESIUM FORMATE, 13 % PEG3350, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 47.41900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.30400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 47.41900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.30400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -3.64208 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 57.40959 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 467 REMARK 465 ASN A 468 REMARK 465 ASP A 469 REMARK 465 TYR A 470 REMARK 465 ASP A 471 REMARK 465 ASP A 472 REMARK 465 THR A 473 REMARK 465 ILE A 474 REMARK 465 PRO A 475 REMARK 465 ILE A 476 REMARK 465 LEU A 477 REMARK 465 ASP A 478 REMARK 465 ALA A 479 REMARK 465 LEU A 480 REMARK 465 LYS A 481 REMARK 465 VAL A 482 REMARK 465 GLU A 497 REMARK 465 ALA A 498 REMARK 465 PHE A 499 REMARK 465 GLU A 500 REMARK 465 ILE A 501 REMARK 465 GLN A 502 REMARK 465 HIS A 503 REMARK 465 GLY A 566 REMARK 465 THR A 567 REMARK 465 GLU A 568 REMARK 465 TYR A 569 REMARK 465 SER A 570 REMARK 465 ALA A 571 REMARK 465 GLU A 572 REMARK 465 HIS A 721 REMARK 465 HIS A 722 REMARK 465 HIS A 723 REMARK 465 HIS A 724 REMARK 465 HIS A 725 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 341 CG CD CE NZ REMARK 480 LYS A 358 CD CE NZ REMARK 480 LYS A 360 CG CD CE NZ REMARK 480 ARG A 374 CD NE CZ NH1 NH2 REMARK 480 LYS A 379 CE NZ REMARK 480 LYS A 404 CG CD CE NZ REMARK 480 PHE A 420 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LYS A 447 CB CG CD CE NZ REMARK 480 GLU A 453 CG CD OE1 OE2 REMARK 480 LYS A 513 CG CD CE NZ REMARK 480 LYS A 523 CG CD CE NZ REMARK 480 LYS A 538 CD CE NZ REMARK 480 LEU A 541 CG CD1 CD2 REMARK 480 LYS A 543 CG CD CE NZ REMARK 480 GLN A 546 CG CD OE1 NE2 REMARK 480 LYS A 557 CG CD CE NZ REMARK 480 ARG A 576 CD NE CZ NH1 NH2 REMARK 480 LYS A 582 CE NZ REMARK 480 GLU A 585 CD OE1 OE2 REMARK 480 GLU A 588 CD OE1 OE2 REMARK 480 LYS A 593 CG CD CE NZ REMARK 480 GLN A 599 CG CD OE1 NE2 REMARK 480 TYR A 620 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 LYS A 621 CG CD CE NZ REMARK 480 ILE A 626 CG1 CG2 CD1 REMARK 480 MET A 627 CG SD CE REMARK 480 TYR A 631 CE1 CE2 CZ OH REMARK 480 LEU A 637 CB CG CD1 CD2 REMARK 480 LYS A 644 CG CD CE NZ REMARK 480 TYR A 657 CD1 CE1 CE2 CZ OH REMARK 480 LYS A 661 CG CD CE NZ REMARK 480 LYS A 665 CG CD CE NZ REMARK 480 LYS A 679 CG CD CE NZ REMARK 480 GLN A 691 CG CD OE1 NE2 REMARK 480 GLU A 696 CG CD OE1 OE2 REMARK 480 LYS A 702 CG CD CE NZ REMARK 480 LYS A 714 CD CE NZ REMARK 480 HIS A 718 CE1 NE2 REMARK 480 ARG A 719 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 402 49.00 -69.53 REMARK 500 ASP A 462 76.31 -116.79 REMARK 500 SER A 660 -34.80 -39.63 REMARK 500 LEU A 711 -134.68 51.01 REMARK 500 ARG A 719 147.77 -171.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LZU A 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4I1P RELATED DB: PDB DBREF 4I1R A 339 719 UNP Q9UDY8 MALT1_HUMAN 339 719 SEQADV 4I1R MET A 338 UNP Q9UDY8 INITIATING METHIONINE SEQADV 4I1R HIS A 720 UNP Q9UDY8 EXPRESSION TAG SEQADV 4I1R HIS A 721 UNP Q9UDY8 EXPRESSION TAG SEQADV 4I1R HIS A 722 UNP Q9UDY8 EXPRESSION TAG SEQADV 4I1R HIS A 723 UNP Q9UDY8 EXPRESSION TAG SEQADV 4I1R HIS A 724 UNP Q9UDY8 EXPRESSION TAG SEQADV 4I1R HIS A 725 UNP Q9UDY8 EXPRESSION TAG SEQRES 1 A 388 MET LEU ALA LYS ASP LYS VAL ALA LEU LEU ILE GLY ASN SEQRES 2 A 388 MET ASN TYR ARG GLU HIS PRO LYS LEU LYS ALA PRO LEU SEQRES 3 A 388 VAL ASP VAL TYR GLU LEU THR ASN LEU LEU ARG GLN LEU SEQRES 4 A 388 ASP PHE LYS VAL VAL SER LEU LEU ASP LEU THR GLU TYR SEQRES 5 A 388 GLU MET ARG ASN ALA VAL ASP GLU PHE LEU LEU LEU LEU SEQRES 6 A 388 ASP LYS GLY VAL TYR GLY LEU LEU TYR TYR ALA GLY HIS SEQRES 7 A 388 GLY TYR GLU ASN PHE GLY ASN SER PHE MET VAL PRO VAL SEQRES 8 A 388 ASP ALA PRO ASN PRO TYR ARG SER GLU ASN CYS LEU CYS SEQRES 9 A 388 VAL GLN ASN ILE LEU LYS LEU MET GLN GLU LYS GLU THR SEQRES 10 A 388 GLY LEU ASN VAL PHE LEU LEU ASP MET CYS ARG LYS ARG SEQRES 11 A 388 ASN ASP TYR ASP ASP THR ILE PRO ILE LEU ASP ALA LEU SEQRES 12 A 388 LYS VAL THR ALA ASN ILE VAL PHE GLY TYR ALA THR CYS SEQRES 13 A 388 GLN GLY ALA GLU ALA PHE GLU ILE GLN HIS SER GLY LEU SEQRES 14 A 388 ALA ASN GLY ILE PHE MET LYS PHE LEU LYS ASP ARG LEU SEQRES 15 A 388 LEU GLU ASP LYS LYS ILE THR VAL LEU LEU ASP GLU VAL SEQRES 16 A 388 ALA GLU ASP MET GLY LYS CYS HIS LEU THR LYS GLY LYS SEQRES 17 A 388 GLN ALA LEU GLU ILE ARG SER SER LEU SER GLU LYS ARG SEQRES 18 A 388 ALA LEU THR ASP PRO ILE GLN GLY THR GLU TYR SER ALA SEQRES 19 A 388 GLU SER LEU VAL ARG ASN LEU GLN TRP ALA LYS ALA HIS SEQRES 20 A 388 GLU LEU PRO GLU SER MET CYS LEU LYS PHE ASP CYS GLY SEQRES 21 A 388 VAL GLN ILE GLN LEU GLY PHE ALA ALA GLU PHE SER ASN SEQRES 22 A 388 VAL MET ILE ILE TYR THR SER ILE VAL TYR LYS PRO PRO SEQRES 23 A 388 GLU ILE ILE MET CYS ASP ALA TYR VAL THR ASP PHE PRO SEQRES 24 A 388 LEU ASP LEU ASP ILE ASP PRO LYS ASP ALA ASN LYS GLY SEQRES 25 A 388 THR PRO GLU GLU THR GLY SER TYR LEU VAL SER LYS ASP SEQRES 26 A 388 LEU PRO LYS HIS CYS LEU TYR THR ARG LEU SER SER LEU SEQRES 27 A 388 GLN LYS LEU LYS GLU HIS LEU VAL PHE THR VAL CYS LEU SEQRES 28 A 388 SER TYR GLN TYR SER GLY LEU GLU ASP THR VAL GLU ASP SEQRES 29 A 388 LYS GLN GLU VAL ASN VAL GLY LYS PRO LEU ILE ALA LYS SEQRES 30 A 388 LEU ASP MET HIS ARG HIS HIS HIS HIS HIS HIS HET LZU A 801 25 HETNAM LZU 10-{2-[(2S)-1-METHYLPIPERIDIN-2-YL]ETHYL}-2- HETNAM 2 LZU (METHYLSULFANYL)-10H-PHENOTHIAZINE HETSYN LZU THIORIDAZINE FORMUL 2 LZU C21 H26 N2 S2 FORMUL 3 HOH *26(H2 O) HELIX 1 1 ALA A 361 LEU A 376 1 16 HELIX 2 2 THR A 387 LEU A 401 1 15 HELIX 3 3 ARG A 435 CYS A 439 5 5 HELIX 4 4 VAL A 442 GLU A 451 1 10 HELIX 5 5 GLY A 509 LEU A 520 1 12 HELIX 6 6 LYS A 524 CYS A 539 1 16 HELIX 7 7 CYS A 539 LYS A 545 1 7 HELIX 8 8 LEU A 574 ALA A 583 1 10 HELIX 9 9 ASP A 642 ALA A 646 5 5 HELIX 10 10 THR A 650 THR A 654 5 5 HELIX 11 11 VAL A 659 LEU A 663 5 5 HELIX 12 12 PRO A 710 LYS A 714 5 5 SHEET 1 A 5 LYS A 379 LEU A 384 0 SHEET 2 A 5 LYS A 343 GLY A 349 1 N LEU A 347 O LEU A 383 SHEET 3 A 5 TYR A 407 ASN A 419 1 O TYR A 411 N ILE A 348 SHEET 4 A 5 ASN A 422 MET A 425 -1 O PHE A 424 N TYR A 417 SHEET 5 A 5 LEU A 440 CYS A 441 -1 O LEU A 440 N MET A 425 SHEET 1 B 6 LYS A 379 LEU A 384 0 SHEET 2 B 6 LYS A 343 GLY A 349 1 N LEU A 347 O LEU A 383 SHEET 3 B 6 TYR A 407 ASN A 419 1 O TYR A 411 N ILE A 348 SHEET 4 B 6 LEU A 456 CYS A 464 1 O VAL A 458 N LEU A 410 SHEET 5 B 6 ILE A 486 ALA A 491 1 O ALA A 491 N LEU A 461 SHEET 6 B 6 GLU A 549 SER A 552 -1 O ARG A 551 N PHE A 488 SHEET 1 C 4 MET A 590 LYS A 593 0 SHEET 2 C 4 GLN A 599 PHE A 608 -1 O LEU A 602 N MET A 590 SHEET 3 C 4 VAL A 611 TYR A 620 -1 O SER A 617 N GLN A 601 SHEET 4 C 4 LEU A 668 LEU A 672 -1 O LEU A 672 N MET A 612 SHEET 1 D 3 TYR A 631 THR A 633 0 SHEET 2 D 3 LEU A 682 CYS A 687 -1 O THR A 685 N THR A 633 SHEET 3 D 3 LYS A 702 GLY A 708 -1 O GLY A 708 N LEU A 682 CISPEP 1 ASN A 432 PRO A 433 0 2.41 CISPEP 2 THR A 654 GLY A 655 0 1.14 CISPEP 3 HIS A 718 ARG A 719 0 4.27 SITE 1 AC1 9 ALA A 345 LYS A 379 VAL A 381 ALA A 394 SITE 2 AC1 9 GLU A 397 LEU A 401 ARG A 576 TRP A 580 SITE 3 AC1 9 MET A 717 CRYST1 94.838 70.608 57.525 90.00 93.63 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010544 0.000000 0.000669 0.00000 SCALE2 0.000000 0.014163 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017419 0.00000